by websites@wisetechcorp.ca | Nov 7, 2025 | PUBLICATIONS
BACKGROUND: Young women with breast cancer (YWBC) experience worse medical and psychosocial outcomes than their older counterparts. Early input from a multidisciplinary team via pre-treatment multidisciplinary cancer conferences (pMCCs) may be important for addressing...
by websites@wisetechcorp.ca | Nov 7, 2025 | PUBLICATIONS
BACKGROUND: Cancer patients of reproductive age are at risk of infertility as a result of their treatment. Oncofertility decision support resources can assist patients with fertility decision-making before treatment yet available oncofertility resources contain...
by websites@wisetechcorp.ca | Nov 7, 2025 | PUBLICATIONS
BACKGROUND: Premenopausal breast cancer patients are at risk of treatment-related infertility. Many patients do not receive sufficient fertility information before treatment. As such, our team developed and alpha tested the Begin Exploring Fertility Options, Risks,...
by websites@wisetechcorp.ca | Nov 7, 2025 | PUBLICATIONS
Purpose: Young women are high users of social media (SM), but information is lacking on whether online supports including SM meet the needs of young women (<40 years) with breast cancer (YWBC). YWBC are a vulnerable population who experience many psychosocial...
by websites@wisetechcorp.ca | Nov 7, 2025 | PUBLICATIONS
BACKGROUND: The breast surgeon, generally the first oncology specialist consulted, is ideally suited to offer fertility preservation (FP) referral to young women with breast cancer (YWBC). In the authors’ 2015 survey of 84 surgeons participating in the...
by websites@wisetechcorp.ca | Nov 7, 2025 | PUBLICATIONS
IMPORTANCE: Infertility can be a devastating adverse effect of cancer treatment for young women. Fertility preservation may be an important and influential factor in treatment decisions. Despite American Society of Clinical Oncology guidelines recommending discussion...
